Oncolytic virotherapy meets the human organoid technology for pancreatic cancers

Oncolytic virotherapy meets the human organoid technology for pancreatic cancers

Bibliographic Details
Main Authors:	Elena Fiorini, Vincenzo Corbo, PhD
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396420302036

Similar Items

Editorial: Oncolytic virotherapy
by: Ahmed Majeed Al-Shammari, et al.
Published: (2023-11-01)

A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy
by: Mary E. Carter, et al.
Published: (2022-02-01)

Oncolytic Virotherapy for Cancer: Clinical Experience
by: Shyambabu Chaurasiya, et al.
Published: (2021-04-01)

Oncolytic virotherapy in hepato‐bilio‐pancreatic cancer: The key to breaking the log jam?
by: Yuwei Li, et al.
Published: (2020-05-01)

Mathematical modelling of oncolytic virotherapy
by: Shabala, A
Published: (2013)

Oncolytic Virotherapy for Hematological Malignancies
by: Swarna Bais, et al.
Published: (2012-01-01)

The combination therapy of oncolytic virotherapy
by: Yue Wang, et al.
Published: (2024-04-01)

Syncytia Formation in Oncolytic Virotherapy
by: Chase Burton, et al.
Published: (2019-12-01)

Progress of oncolytic virotherapy for neuroblastoma
by: Xiao-Tong Chen, et al.
Published: (2022-11-01)

Delivery and Biosafety of Oncolytic Virotherapy
by: Lizhi Li, et al.
Published: (2020-04-01)

Lung cancer and oncolytic virotherapy——enemy's enemy
by: Zhang Li, et al.
Published: (2023-01-01)

Editorial: Oncolytic virotherapy, volume II
by: Ahmed Majeed Al-Shammari, et al.
Published: (2025-01-01)

Emerging delivery strategy for oncolytic virotherapy
by: Jiao Zhu, et al.
Published: (2024-06-01)

The use of oncolytic virotherapy in the neoadjuvant setting
by: Eric Bartee, et al.
Published: (2022-04-01)

Oncolytic virotherapy in head and neck cancer: A hope?
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-03-01)

Oncolytic virotherapy in gastric cancer: Towards precision therapeutics
by: Muhammad Ikrama, et al.
Published: (2024-04-01)

Oncolytic virotherapy in cancer treatment: challenges and optimization prospects
by: Lingjuan Chen, et al.
Published: (2023-12-01)

Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer culturesResearch in context
by: Theresa E. Schäfer, et al.
Published: (2024-07-01)

Transforming the prostatic tumor microenvironment with oncolytic virotherapy
by: Matthew J. Atherton, et al.
Published: (2018-07-01)

Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances
by: Amy Kwan, et al.
Published: (2021-06-01)

Oncolytic virotherapy for metastatic breast cancer – a case report
by: Benjamin Gesundheit, et al.
Published: (2023-06-01)

Presage of oncolytic virotherapy for oral cancer with herpes simplex virus
by: Yoshiaki Yura
Published: (2017-05-01)

Tumor Tropism of DNA Viruses for Oncolytic Virotherapy
by: Junior A. Enow, et al.
Published: (2023-11-01)

Oncolytic virotherapy targeting the IL15 pathway
by: So Young Yoo, et al.
Published: (2023-12-01)

Talimogene laherparepvec: First in class oncolytic virotherapy
by: Robert M. Conry, et al.
Published: (2018-04-01)

Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy
by: Zhongbing Qi, et al.
Published: (2022-09-01)

Exploiting tumor epigenetics to improve oncolytic virotherapy
by: Nicole E. Forbes, et al.
Published: (2013-09-01)

Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches
by: Qing Ji, et al.
Published: (2022-08-01)

Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
by: Alberto Reale, et al.
Published: (2021-12-01)

Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.
by: Bazan-Peregrino, M, et al.
Published: (2008)

An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer
by: Dubravko Forčić, et al.
Published: (2024-08-01)

Cavitary pulmonary appearance of metastatic rectal cancer after oncolytic virotherapy
by: Chien-Yang Liao, et al.
Published: (2022-11-01)

Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma
by: Sarah Mansouri, et al.
Published: (2023-02-01)

Oncolytic Virotherapy Increases the Detection of Microscopic Metastatic Disease at Time of Staging Laparoscopy for Pancreatic Adenocarcinoma
by: Christopher J. LaRocca, et al.
Published: (2016-05-01)

The replicability of oncolytic virus: Defining conditions in tumor virotherapy
by: Jianjun Paul Tian
Published: (2011-05-01)

Effects of virus-induced immunogenic cues on oncolytic virotherapy
by: Darshak K. Bhatt, et al.
Published: (2024-11-01)

Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis
by: Jia-Li Zhao, et al.
Published: (2024-11-01)

Proliferating Cell Nuclear Antigen in the Era of Oncolytic Virotherapy
by: Amy Kwan, et al.
Published: (2024-08-01)

A bibliometric analysis of oncolytic virotherapy combined with immunotherapy
by: Ting Zhang, et al.
Published: (2024-12-01)

Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma
by: Mason J. Webb, et al.
Published: (2023-05-01)